As shown in Supplementary Fig. 3a, BCR-ABL positive B-ALL patients with high TSPAN32 expression had a significantly higher probability of overall survival when compared to those with low TSPAN32 expression of. This evidence concerns the gene ABL1 and acute lymphoblastic leukemia.